source
- AstraZeneca launches $1.5 billion annual cost-saving plan to offset late-stage trial setbacksAstraZeneca announced a new cost‑saving initiative targeting $1.5 billion of annual expenses. The move follows a series of late‑stage clinical trial failures that have pressured the company's pipe…
- Congress must restore independence of scientific advisory panels after controversial firingsThe authors note the recent dismissal of two vice chairs of the U.S. Preventive Services Task Force by HHS Secretary Robert F. Kennedy Jr., stressing the panel’s role in reviewing evidence to guide…